Compile Data Set for Download or QSAR
Found 67 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 6115
LigandPNGBDBM109327(US8609666, 47)
Affinity DataIC50:  8nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109313(US8609666, 33)
Affinity DataIC50:  9nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109317(US8609666, 37)
Affinity DataIC50:  10nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109314(US8609666, 34)
Affinity DataIC50:  13nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109336(US8609666, 56)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109341(US8609666, 61)
Affinity DataIC50:  15nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109316(US8609666, 36)
Affinity DataIC50:  18nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109294(US8609666, 14)
Affinity DataIC50:  19nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109322(US8609666, 42)
Affinity DataIC50:  23nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109293(US8609666, 13)
Affinity DataIC50:  24nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109319(US8609666, 39)
Affinity DataIC50:  26nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109328(US8609666, 48)
Affinity DataIC50:  27nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109290(US8609666, 10)
Affinity DataIC50:  28nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109347(US8609666, 67)
Affinity DataIC50:  30nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109303(US8609666, 23)
Affinity DataIC50:  34nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109318(US8609666, 38)
Affinity DataIC50:  43nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109315(US8609666, 35)
Affinity DataIC50:  48nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109343(US8609666, 63)
Affinity DataIC50:  57nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109331(US8609666, 51)
Affinity DataIC50:  62nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109321(US8609666, 41)
Affinity DataIC50:  63nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109296(US8609666, 16)
Affinity DataIC50:  64nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109309(US8609666, 29)
Affinity DataIC50:  66nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109311(US8609666, 31)
Affinity DataIC50:  73nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109304(US8609666, 24)
Affinity DataIC50:  74nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109292(US8609666, 12)
Affinity DataIC50:  75nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109300(US8609666, 20)
Affinity DataIC50:  77nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109340(US8609666, 60)
Affinity DataIC50:  80nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109324(US8609666, 44)
Affinity DataIC50:  82nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109332(US8609666, 52)
Affinity DataIC50:  83nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109334(US8609666, 54)
Affinity DataIC50:  89nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109295(US8609666, 15)
Affinity DataIC50:  93nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109289(US8609666, 9)
Affinity DataIC50:  108nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109299(US8609666, 19)
Affinity DataIC50:  128nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109297(US8609666, 17)
Affinity DataIC50:  132nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109337(US8609666, 57)
Affinity DataIC50:  137nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109335(US8609666, 55)
Affinity DataIC50:  139nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109320(US8609666, 40)
Affinity DataIC50:  144nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109301(US8609666, 21)
Affinity DataIC50:  169nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109339(US8609666, 59)
Affinity DataIC50:  220nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109342(US8609666, 62)
Affinity DataIC50:  225nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109291(US8609666, 11)
Affinity DataIC50:  255nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109283(US8609666, 3)
Affinity DataIC50:  290nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109330(US8609666, 50)
Affinity DataIC50:  303nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109310(US8609666, 30)
Affinity DataIC50:  304nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109329(US8609666, 49)
Affinity DataIC50:  329nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109325(US8609666, 45)
Affinity DataIC50:  335nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109326(US8609666, 46)
Affinity DataIC50:  346nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109284(US8609666, 4)
Affinity DataIC50:  350nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109333(US8609666, 53)
Affinity DataIC50:  412nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM109323(US8609666, 43)
Affinity DataIC50:  459nMAssay Description:The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: